Pet Cancer Therapeutics Market Size Forecast: Revenue and CAGR by 2029

November 12, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Pet Cancer Therapeutics Industry By The Forecast Year 2029?

The pet cancer therapeutics market has experienced significant growth in recent years. This market is anticipated to expand from $0.39 billion in 2024 to $0.43 billion by 2025, progressing at a compound annual growth rate (CAGR) of 10.6%. Historically, this expansion has been propelled by an increase in pet ownership, advancements in veterinary medicine, greater awareness of pet health, the humanization of pets, and the expansion of veterinary services.

The pet cancer therapeutics market size is anticipated to undergo substantial growth in the coming years. It is projected to expand to $0.65 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.6%. This expansion during the forecast period is fueled by an expanding aging pet population, ongoing progress in cancer treatments, an increase in veterinary oncology services, the availability of pet insurance and healthcare plans, and the global spread of pet care services. Significant trends expected in this period involve the emergence of nutraceuticals and integrative therapies, improved accessibility to targeted diagnostic tests, greater collaboration between veterinary and human oncology, the introduction of innovative chemotherapeutic agents, and enhanced awareness and education among pet owners.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9984&type=smp

Which Drivers Are Impacting The Pet Cancer Therapeutics Market?

Rising spending on pet healthcare is projected to fuel the expansion of the pet cancer therapeutics market in the future. This expenditure encompasses funds allocated for veterinary care, medications, and other health-related costs for companion animals. The increasing financial outlay on pet health signifies an escalating inclination among pet owners to invest in their pets’ welfare, which in turn could lead to a greater need for pet cancer therapeutics. As an illustration, the 2023 State of the Industry Report, released by the North American Pet Health Insurance Association (NAPHIA), a US-based association of pet health insurance organizations, indicated that 4.8 million pets were insured in the United States by the end of 2022, representing a 22% rise from 2021. Consequently, the uptick in pet healthcare spending is a key driver for the pet cancer therapeutics market.

What Are The Emerging Segments Gaining Attention In The Pet Cancer Therapeutics Market?

The pet cancer therapeutics market covered in this report is segmented –

1) By Cancer Type: Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer

2) By Species: Dogs, Cats, Other Species

3) By Therapy: Chemotherapy, Radiation Therapy, Immunotherapy, TomoTherapy, Other Therapies

4) By End User: Veterinary Hospitals, Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, Other End Users

Subsegments:

1) By Melanoma: Surgical Interventions, Chemotherapy, Immunotherapy, Targeted Therapy

2) By Mast Cell Cancer: Surgery, Chemotherapy, Tyrosine Kinase Inhibitors, Radiation Therapy

3) By Lymphoma: Chemotherapy Protocols, Steroid Therapy, Radiation Therapy, Immunotherapy

4) By Mammary And Squamous Cell Cancer: Surgical Treatment, Chemotherapy, Radiation Therapy, Palliative Care Options

How Are Emerging Market Trends Shaping The Pet Cancer Therapeutics Industry Landscape?

Major companies in the pet cancer therapeutics market are developing advanced solutions like epigenetic technology to improve treatment effectiveness and precise targeting of cancer cells, ultimately leading to better outcomes for pets with cancer. Epigenetic technology refers to methods that adjust gene expression without altering the underlying DNA sequence, often influencing cellular behavior and potential therapeutic results. For instance, in April 2024, VolitionRx Limited, a US-based multinational epigenetics company, unveiled the Nu.Q Vet Cancer Test. This Nu.Q Vet Cancer Test runs on the Element i+ Analyzer, delivering quick results—typically within about 6 minutes. It employs an enzyme-linked immunosorbent assay to detect circulating nucleosomes in the blood, which can suggest the presence of cancer.

Who Are The Major Companies Operating In The Pet Cancer Therapeutics Market?

Major companies operating in the pet cancer therapeutics market include AB Science, Boehringer Ingelheim GmbH, Elanco Animal Health, ELIAS Animal Health, Zoetis Inc., Anivive Lifesciences Inc., QBiotics Group Ltd., Regeneus Ltd., VetDC Inc., PetCure Oncology at Veterinary Radiosurgery and Imaging Center, Torigen Pharmaceuticals Inc., virology and bacteriology, Nippon Zenyaku Kogyo Co. Ltd., Vivesto AB, Dechra Pharmaceuticals plc, Norbrook Laboratories Ltd., AdvaVet Inc., Oasmia Pharmaceuticals AB, Zenoaq Co. Ltd., Morphogenesis Inc., Sumitomo Pharma Animal Health Co., Vetivax, CarthroniX Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pet-cancer-therapeutics-global-market-report

Which Regional Markets Are Contributing Most To The Pet Cancer Therapeutics Industry Expansion?

North America was the largest region in the pet cancer therapeutics market in 2024. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Pet Cancer Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9984&type=smp

Browse Through More Reports Similar to the Global Pet Cancer Therapeutics Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795